Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: A multicentre study

Qi Yang(Chinese PLA General Hospital), Jingwei Wei(Shandong Institute of Automation), Xiaohan Hao(University of Chinese Academy of Sciences), De-Xing Kong(Zhejiang University), Xiaoling Yu(Chinese PLA General Hospital), Tianan Jiang(Zhejiang University), Junqing Xi(Chinese PLA General Hospital), Wenjia Cai(Chinese PLA General Hospital), Yanchun Luo(Chinese PLA General Hospital), Xiang Jing(Tianjin Medical University), Yilin Yang(Air Force Medical University), Zhigang Cheng(Chinese PLA General Hospital), Jinyu Wu(The First Hospital of Kunming), Huiping Zhang(Anshan Hospital), Jin-tang Liao, Pei Zhou(Wuhan General Hospital of Guangzhou), Yu Song(Second Affiliated Hospital of Dalian Medical University), Yao Zhang(Beijing Ditan Hospital), Zhiyu Han(Chinese PLA General Hospital), Wen Cheng(Third Affiliated Hospital of Harbin Medical University), Lina Tang(Fujian Provincial Cancer Hospital), Fangyi Liu(Chinese PLA General Hospital), Jianping Dou(Chinese PLA General Hospital), Rongqin Zheng(Sun Yat-sen University), Jie Yu(Chinese PLA General Hospital), Jie Tian(Chinese Academy of Sciences), Ping Liang(Chinese PLA General Hospital)
EBioMedicine
April 27, 2020
Cited by 117Open Access
Full Text

Abstract

BackgroundThe diagnosis performance of B-mode ultrasound (US) for focal liver lesions (FLLs) is relatively limited. We aimed to develop a deep convolutional neural network of US (DCNN-US) for aiding radiologists in classification of malignant from benign FLLs.Materials and methodsThis study was conducted in 13 hospitals and finally 2143 patients with 24,343 US images were enrolled. Patients who had non-cystic FLLs with pathological results were enrolled. The FLLs from 11 hospitals were randomly divided into training and internal validations (IV) cohorts with a 4:1 ratio for developing and evaluating DCNN-US. Diagnostic performance of the model was verified using external validation (EV) cohort from another two hospitals. The diagnosis value of DCNN-US was compared with that of contrast enhanced computed tomography (CT)/magnetic resonance image (MRI) and 236 radiologists, respectively.FindingsThe AUC of ModelLBC for FLLs was 0.924 (95% CI: 0.889–0.959) in the EV cohort. The diagnostic sensitivity and specificity of ModelLBC were superior to 15-year skilled radiologists (86.5% vs 76.1%, p = 0.0084 and 85.5% vs 76.9%, p = 0.0051, respectively). Accuracy of ModelLBC was comparable to that of contrast enhanced CT (both 84.7%) but inferior to contrast enhanced MRI (87.9%) for lesions detected by US.InterpretationDCNN-US with high sensitivity and specificity in diagnosing FLLs shows its potential to assist less-experienced radiologists in improving their performance and lowering their dependence on sectional imaging in liver cancer diagnosis.


Related Papers

No related papers found

Powered by citation graph analysis